MCMartin D. Cheatle

Martin D. Cheatle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martin D. Cheatle has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Suicidality in patients with chronic noncancer pain and co-morbid substance use: A scoping review of the literature

    by Martin D. Cheatle, Yoonjae Lee, Jonathan Zhu, Gabriel Kass, Sakina J. Rizvi

  • Chronic postsurgical pain: risk assessment and mitigation

    by Martin D. Cheatle, Isabella Rosales, Kai-Hua Chang, Yoonjae Lee

    Purpose of the review: Chronic postsurgical pain (CPSP) and persistent postoperative opioid use (PPOU) are two of the most common complications of a number of surgical interventions, which can cause significant personal and economic negative consequences. This review outlines known and potential risk factors for CPSP and PPOU and approaches to reduce these risk factors. Recent findings: Modifiable risk factors for developing CPSP include psychological distress, preoperative pain intensity, and perioperative opioid exposure. Although less studied, psychological comorbidities are also risk factors for PPOU. Evidence-based mitigation strategies include psychological interventions and perioperative opioid sparing. Summary: A number of perioperative risk factors for developing CPSP and PPOU have been identified, and anesthesiologists should be cognizant of these risk factors and potential risk mitigation strategies. Additional prospective studies are needed to further develop easily adoptable, evidence-based interventions to reduce the incidence of CPSP and PPOU.


  • Prediction of opioid use disorder among patients with chronic non-cancer pain receiving long-term opioid therapy

    by Christal N Davis, Yoonjae Lee, Martin D Cheatle

    Objective: Assessing opioid use disorder risk in patients prescribed long-term opioid therapy for management of chronic non-cancer pain is critical for prevention and early intervention. Design: Case-control study. Setting: Pain management and primary care clinics, and substance use treatment facilities. Subjects: Participants are 1300 patients with chronic non-cancer pain (59.68% women; mean age = 49.03 years), 409 of whom developed opioid use disorder. Methods: We compared the performance of 3 machine learning models that used the Opioid Risk Tool for Opioid Use Disorder alone with those that incorporated an expanded set of clinical predictors. Results: The Opioid Risk Tool for Opioid Use Disorder showed strong performance (precision = 0.91; specificity = 0.96). Models that incorporated additional predictors showed improved performance on precision-recall area under the curve and F1 scores, particularly the random forest and eXtreme Gradient Boosting models. Aside from the Opioid Risk Tool for Opioid Use Disorder, the most important features in the expanded models were nicotine dependence, marital status, opioid misuse behaviors, and pain interference and catastrophizing. Conclusions: A stepwise approach that employs the Opioid Risk Tool for Opioid Use Disorder as a preliminary screener followed by a more in-depth assessment of clinical predictors among high-risk individuals may offer a feasible strategy to optimize efficiency and precision in risk stratification. Future work should refine and validate this framework in diverse population and care settings, as well as examine its integration into clinical workflow to enhance the identification of chronic non-cancer pain patients at risk for opioid use disorder.


  • Correlates of mental defeat in individuals with chronic non-cancer pain on long-term opioid therapy

    by Yoonjae Lee, Nicholas A Giordano, Peggy A Compton, Nicole K Y Tang, Rosemary C Polomano, Martin D Cheatle

    Background: Individuals with chronic non-cancer pain (CNCP) often present with significant challenges that can impact physical, psychological, and social well-being. Mental defeat is a critical consequence of CNCP being a known predictor of suicidality. This study examines the relationships between specific psychological and coping factors and mental defeat among individuals with CNCP on long-term opioid therapy (LTOT). Design: A cross-sectional study of secondary data. Setting: Primary care, pain, and substance abuse clinics in Pennsylvania, Washington, and Utah. Subjects: 744 adults with CNCP receiving LTOT (≥ 6 months). Methods: Anxiety and depression symptoms and pain coping strategies were examined with hierarchical multiple linear regression analysis to describe their relationship to mental defeat. In an exploratory analysis, we also stratified the sample by the presence of opioid use disorder (OUD) to determine if the associations were differently represented. Results: After controlling for covariates, anxiety (β = 7.07, P < .001) and depression symptoms (β = 14.17, P < .001) were statistically significant correlates of increased mental defeat. Diverting attention (β = 0.31, P < .05), coping self-statements (β = -0.30, P < .05), and catastrophizing (β = 1.47, P < .001) were significant correlates, explaining 51% of the variance in mental defeat (P < .001). Exploratory analysis revealed subgroup differences, such that while depression symptoms and catastrophizing were significant correlates of mental defeat in persons with and without OUD, anxiety and diverting attention were significant only in persons without OUD. Conclusions: These findings identify key psychological and coping correlates of mental defeat in persons with CNCP on LTOT, informing the development of interventions to mitigate it, and thereby reducing the risk of suicide in this vulnerable population.


  • Open Access

    Pain, Substance Use Disorder and Suicide: on the Edge

    by Martin D. Cheatle

    Purpose of Review: Chronic pain and substance use disorders (SUDs) are both common conditions worldwide and produce major social, economic, and human costs. Individuals coping with chronic pain and comorbid SUD may experience high rates of stress, isolation, functional decline, and depression, and many have a high risk of suicide. The purpose of this narrative review is to highlight the hidden epidemic of suicide among individuals with pain and concomitant SUD, outline unique risk factors in this patient population, and discuss evidence-based pharmacologic and non-pharmacologic interventions to mitigate suicide risk. Recent Findings: The prevalence of suicidal ideation among patients with chronic non-cancer pain (CNCP) is significant, ranging from 20 to 50%. It has been estimated that 40% of patients seeking treatment for SUDs report a history of suicide attempts. Risk factors for suicide in populations with CNCP pain include pain intensity and type, sleep disturbance, opioid prescribing patterns and opioid tapering. Evidence-based pharmacologic treatments include antidepressant medications, antiepileptic drugs and more novel drugs such as ketamine and buprenorphine. Non-pharmacologic approaches, such as cognitive behavioral therapy and acceptance commitment therapy, have shown efficacy in improving mood, sleep and function. Summary: There is a high rate of suicide among individuals with CNCP and SUDs. Identifying unique contributing factors for suicide among this vulnerable patient population can inform effective interventions to reduce the risk of suicide.


  • Open Access

    Trajectories and predictors of high-occurrence pain flares in ambulatory cancer patients on opioids

    by Salimah H Meghani, Ryan Quinn, Andrew Robinson, Jesse Chittams, Neha Vapiwala, Mary Naylor, Martin Cheatle, George J Knafl

    Pain flares have a substantive impact on the quality of life and well-being of patients with cancer. We identified longitudinal trajectories (clusters) of cancer pain flares in ambulatory patients and sociodemographic and clinical predictors of these trajectories. In a prospective cohort study using ecological momentary assessment (mEMA), we collected patient-reported daily pain flare ratings data over 5 months and identified predictors and correlates using validated measures. The mean age of the sample (N = 270) was 60.9 years (SD = 11.2), 64.8% were female, and 32.6% self-identified as African American. Four pain flare clusters were identified. The “high-occurrence” cluster (23% of patients) experienced 5.5 (SD = 5.47) daily flares, whereas low-moderate clusters (77%) reported 2.4 (SD = 2.74) daily flares (P < .000). Those in the high-occurrence cluster reported higher pain scores (P = .000), increased pain-related interference (P = .000), depressive symptoms (P = .023), lower quality of life (P = .001), and reduced pain self-efficacy (P = .006). Notably, 67.2% of those prescribed opioids as needed (PRN only) were in the high-occurrence pain flare cluster, compared with 27.9% with PRN and around-the-clock opioid prescriptions (P = .024). Individual predictors of high-occurrence pain flares were income below $30 000, unemployment, being African American, lower education level, Medicaid insurance, current opioid misuse (COMM), baseline inpatient hospital stay duration, and PRN-only opioid regimen. In the multiple predictor model, lower education level, unemployment, COMM score, extended inpatient duration, and PRN-only opioid regimen remained significant. In ambulatory patients with cancer, high occurrence of pain flares may be mitigated by attention to opioid prescription factors and addressing social determinants of health needs of underserved patients.

  • Suicidal thoughts and behaviors in patients with chronic pain, with and without co-occurring opioid use disorder

    by Martin D Cheatle, Nicholas A Giordano, Kristy Themelis, Nicole K Y Tang

    Background: Individuals with chronic pain and a co-occurring substance use disorder present higher risk of suicide, but the individual and joint impacts of chronic pain and substance use disorders on suicide risk are not well defined. The objective of this study was to exam the factors associated with suicidal thoughts and behaviors in a cohort of patients with chronic non-cancer pain (CNCP), with or without concomitant opioid use disorder (OUD). Design: Cross sectional cohort design Setting: Primary care clinics, pain clinics, and substance abuse treatment facilities in Pennsylvania, Washington, and Utah Subjects: In total, 609 adults with CNCP treated with long-term opioid therapy (>/= 6 months) who either developed an OUD (cases, n = 175) or displayed no evidence of OUD (controls, n = 434). Methods: The predicted outcome was elevated suicidal behavior in patients with CNCP as indicated by a Suicide Behavior Questionnaire-Revised (SBQ-R) score of 8 or above. The presence of CNCP and OUD were key predictors. Covariates included demographics, pain severity, psychiatric history, pain coping, social support, depression, pain catastrophizing and mental defeat. Results: Participants with CNCP and co-occurring OUD had an increased odds ratio of 3.44 in reporting elevated suicide scores as compared to participants with chronic pain only. Multivariable modeling revealed that mental defeat, pain catastrophizing, depression, and having chronic pain, and co-occurring OUD significantly increased the odds of elevated suicide scores. Conclusions: Patients with CNCP and co-morbid OUD are associated with a 3-fold increase in risk of suicide.